Ignite Creation Date:
2024-05-06 @ 2:32 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02065856
Status:
COMPLETED
Last Update Posted:
2015-01-14
First Post:
2014-01-20
Brief Title:
An Open Trial to Assess the Tolerability of AVANZ Salsola Immunotherapy
Sponsor:
ALK-Abelló AS
Organization:
ALK-Abelló AS
Organization Data
Organization:
ALK-Abelló AS
Class:
INDUSTRY
Study ID:
2013-001728-20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ALK-Abelló AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None